Improved Diagnostic Yield in Recessive Intellectual Disability Utilizing Systematic Whole Exome Sequencing Data Reanalysis
- PMID: 39748273
- DOI: 10.1111/cge.14692
Improved Diagnostic Yield in Recessive Intellectual Disability Utilizing Systematic Whole Exome Sequencing Data Reanalysis
Abstract
Recent advances in next generation sequencing (NGS) have positioned whole exome sequencing (WES) as an efficient first-tier method in genetic diagnosis. However, despite the diagnostic yield of 35%-50% in intellectual disability (ID) many patients still remain undiagnosed due to inherent limitations and bioinformatic short-comings. In this study, we reanalyzed WES data from 159 Iranian families showing recessively inherited ID. The reanalysis was conducted with an initial clinical re-evaluation of the patients and their families, followed by data reanalysis using two updated bioinformatic pipelines. In the first phase, the BWA-GATK pipeline was utilized for alignment and variant calling, with subsequent variant annotation by the ANNOVAR tool. This approach yielded causative variants in 17 families (10.6%). Among these, six genes (MAZ, ACTR5, AKTIP, MIX23, SERPINB12, and CDC25B) were identified as novel candidates potentially associated with ID, supported by bioinformatics functional annotation and segregation analysis. In the second phase, families with negative results were reassessed using the Illumina DRAGEN Bio-IT platform for variant-calling, and Ilyome, a newly developed web-based tool, for annotation. The second phase identified likely pathogenic variants in two additional families, increasing the total diagnostic yield to 11.9% which is consistent with other studies conducted on cohorts of patients with ID. In conclusion, identification of co-segregating variants in six novel candidate genes in this study, emphasizes once more on the potential of WES reanalysis to uncover previously unknown gene-disease associations. Notably, it demonstrates that systematic reanalysis of WES data using updated bioinformatic tools and a thorough review of the literature for new gene-disease associations while performing phenotypic re-evaluation, can improve diagnostic outcome of WES in recessively inherited ID. Consequently, if performed within a 1-3 year period, it can reduce the number of cases that may require other costly diagnostic methods such as whole genome sequencing.
Keywords: intellectual disability; novel genes; reanalysis; runs of homozygosity (RoH); whole exome sequencing.
© 2025 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Reanalysis of exome sequencing data of intellectual disability samples: Yields and benefits.Clin Genet. 2018 Dec;94(6):495-501. doi: 10.1111/cge.13438. Epub 2018 Sep 12. Clin Genet. 2018. PMID: 30125339
-
Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context.Eur J Pediatr. 2024 Jan;183(1):345-355. doi: 10.1007/s00431-023-05279-4. Epub 2023 Oct 27. Eur J Pediatr. 2024. PMID: 37889289 Free PMC article.
-
Reanalysis of whole exome sequencing data in patients with epilepsy and intellectual disability/mental retardation.Gene. 2019 Jun 5;700:168-175. doi: 10.1016/j.gene.2019.03.037. Epub 2019 Mar 21. Gene. 2019. PMID: 30904718
-
Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.Front Immunol. 2022 Jun 30;13:906328. doi: 10.3389/fimmu.2022.906328. eCollection 2022. Front Immunol. 2022. PMID: 35874679 Free PMC article. Review.
-
Whole exome sequencing revealed variants in four genes underlying X-linked intellectual disability in four Iranian families: novel deleterious variants and clinical features with the review of literature.BMC Med Genomics. 2023 Oct 11;16(1):239. doi: 10.1186/s12920-023-01680-y. BMC Med Genomics. 2023. PMID: 37821930 Free PMC article. Review.
References
-
- D. R. Patel, M. D. Cabral, A. Ho, and J. Merrick, “A Clinical Primer on Intellectual Disability,” Translational Pediatrics 9, no. 1 (2020): S23–S35.
-
- L. E. Vissers, C. Gilissen, and J. A. Veltman, “Genetic Studies in Intellectual Disability and Related Disorders,” Nature Reviews Genetics 17, no. 1 (2016): 9–18.
-
- N. Maia, M. J. Nabais Sá, M. Melo‐Pires, A. P. M. de Brouwer, and P. Jorge, “Intellectual Disability Genomics: Current State, Pitfalls and Future Challenges,” BMC Genomics 22, no. 1 (2021): 909.
-
- S. Srivastava, J. A. Love‐Nichols, K. A. Dies, et al., “Meta‐Analysis and Multidisciplinary Consensus Statement: Exome Sequencing Is a First‐Tier Clinical Diagnostic Test for Individuals With Neurodevelopmental Disorders,” Genetics in Medicine 21, no. 11 (2019): 2413–2421.
-
- K. Y. Sánchez‐Luquez, M. X. Carpena, S. M. Karam, and L. Tovo‐Rodrigues, “The Contribution of Whole‐Exome Sequencing to Intellectual Disability Diagnosis and Knowledge of Underlying Molecular Mechanisms: A Systematic Review and Meta‐Analysis,” Mutation Research, Reviews in Mutation Research 790 (2022): 108428.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous